AR052952A1 - Composiciones farmaceuticas de 3'-l-valina ester de beta-d-2'-c-metil-ribofuranosil citidina - Google Patents
Composiciones farmaceuticas de 3'-l-valina ester de beta-d-2'-c-metil-ribofuranosil citidinaInfo
- Publication number
- AR052952A1 AR052952A1 ARP060101133A ARP060101133A AR052952A1 AR 052952 A1 AR052952 A1 AR 052952A1 AR P060101133 A ARP060101133 A AR P060101133A AR P060101133 A ARP060101133 A AR P060101133A AR 052952 A1 AR052952 A1 AR 052952A1
- Authority
- AR
- Argentina
- Prior art keywords
- wet
- granules
- citidine
- beta
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
Una composicion farmacéutica y granulados, preparados a tra'ves de un procedimiento de granulacion en humedo. La composicion farmacéutica y los granulados contienen un compuesto terapéutico por ejemplo, 3'-L-valina éster de beta-D-2'-C-metil- ribofuranosil citidina (Val-mC y ol) y sus sales, ésteres, profármacos o derivados. Reivindicacion 1: Un método para preparar una composicion farmacéutica que comprende los apsos de: a) formar una mezcla en polvo del compuesto terapéutico, por ejemplo, val-mCyd y por lo menos un excipiente farmacéuticamente aceptable; b) agregar un líquido de granulacion a la mezcla en polvo bajo agitacion para formar una masa humeda; c) granular la masa humeda para formar granulos humedos; y d) secar los granulados humedos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66473305P | 2005-03-24 | 2005-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR052952A1 true AR052952A1 (es) | 2007-04-11 |
Family
ID=37024189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060101133A AR052952A1 (es) | 2005-03-24 | 2006-03-22 | Composiciones farmaceuticas de 3'-l-valina ester de beta-d-2'-c-metil-ribofuranosil citidina |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20080207533A1 (es) |
| EP (1) | EP1865926A2 (es) |
| JP (1) | JP2008546635A (es) |
| KR (1) | KR20080011278A (es) |
| CN (1) | CN101146519A (es) |
| AR (1) | AR052952A1 (es) |
| AU (1) | AU2006226521A1 (es) |
| BR (1) | BRPI0609442A2 (es) |
| CA (1) | CA2602000A1 (es) |
| GT (1) | GT200600119A (es) |
| MX (1) | MX2007011704A (es) |
| PE (1) | PE20061352A1 (es) |
| RU (1) | RU2007139105A (es) |
| TW (1) | TW200724168A (es) |
| WO (1) | WO2006100087A2 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| KR20030036189A (ko) | 2000-05-26 | 2003-05-09 | 이데닉스(케이만)리미티드 | 플라비바이러스 및 페스티바이러스의 치료방법 및 조성물 |
| KR20050088079A (ko) | 2002-11-15 | 2005-09-01 | 이데닉스 (케이만) 리미티드 | 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이 |
| JP5527921B2 (ja) * | 2006-12-22 | 2014-06-25 | エスエス製薬株式会社 | 苦味を隠蔽した経口固形組成物 |
| US9814776B2 (en) * | 2013-07-31 | 2017-11-14 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical preparation comprising aminopyrazole derivative |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003248748A1 (en) * | 2002-06-28 | 2004-01-19 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
-
2006
- 2006-03-17 GT GT200600119A patent/GT200600119A/es unknown
- 2006-03-22 AR ARP060101133A patent/AR052952A1/es not_active Application Discontinuation
- 2006-03-23 TW TW095110055A patent/TW200724168A/zh unknown
- 2006-03-23 BR BRPI0609442-2A patent/BRPI0609442A2/pt not_active Application Discontinuation
- 2006-03-23 RU RU2007139105/15A patent/RU2007139105A/ru unknown
- 2006-03-23 CN CNA200680009607XA patent/CN101146519A/zh active Pending
- 2006-03-23 MX MX2007011704A patent/MX2007011704A/es not_active Application Discontinuation
- 2006-03-23 US US11/909,312 patent/US20080207533A1/en not_active Abandoned
- 2006-03-23 KR KR1020077024318A patent/KR20080011278A/ko not_active Application Discontinuation
- 2006-03-23 JP JP2008502333A patent/JP2008546635A/ja active Pending
- 2006-03-23 CA CA002602000A patent/CA2602000A1/en not_active Abandoned
- 2006-03-23 AU AU2006226521A patent/AU2006226521A1/en not_active Abandoned
- 2006-03-23 WO PCT/EP2006/002693 patent/WO2006100087A2/en active Application Filing
- 2006-03-23 PE PE2006000337A patent/PE20061352A1/es not_active Application Discontinuation
- 2006-03-23 EP EP06723676A patent/EP1865926A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007011704A (es) | 2007-11-15 |
| KR20080011278A (ko) | 2008-02-01 |
| RU2007139105A (ru) | 2009-04-27 |
| JP2008546635A (ja) | 2008-12-25 |
| TW200724168A (en) | 2007-07-01 |
| WO2006100087A2 (en) | 2006-09-28 |
| WO2006100087A3 (en) | 2007-02-15 |
| BRPI0609442A2 (pt) | 2010-04-06 |
| AU2006226521A1 (en) | 2006-09-28 |
| CN101146519A (zh) | 2008-03-19 |
| GT200600119A (es) | 2006-10-25 |
| CA2602000A1 (en) | 2006-09-28 |
| US20080207533A1 (en) | 2008-08-28 |
| PE20061352A1 (es) | 2007-01-11 |
| EP1865926A2 (en) | 2007-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200901277A1 (ru) | Фармацевтические составы, содержащие пропиленгликольгидрат дапаглифлозина | |
| UY31867A (es) | Nuevas formulaciones farmacéuticas sólidas que comprenden bibw 2992 | |
| AR056873A1 (es) | Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas | |
| BRPI0721651A8 (pt) | Comprimido farmacêutico e usos deste na fabricação de um medicamento para tratamento de trombocitopenia e para agonizar o receptor tpo | |
| UY31046A1 (es) | Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones | |
| UA110012C2 (uk) | Лікарські форми для перорального застосування, що містять ацетат лікарбазепіну | |
| AR041370A1 (es) | Formulaciones farmaceuticas solidas que comprenden telmisartano y su preparacion | |
| AR052952A1 (es) | Composiciones farmaceuticas de 3'-l-valina ester de beta-d-2'-c-metil-ribofuranosil citidina | |
| RS54329B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS | |
| DOP2010000387A (es) | Compuestos pirazolicos 436 | |
| AR063096A1 (es) | Pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina | |
| UY31406A1 (es) | "producto de dispersion solida que contiene un compuesto a base de n-aril urea". | |
| WO2008154083A3 (en) | Compounds, compositions and methods for the treatment of synucleinopathies | |
| DOP2013000191A (es) | Derivados de heteroarilo como modulares de nachr alfa 7 | |
| AR069508A1 (es) | Derivados de quinolina 057; un proceso para su preparacion; una composicion farmaceutica; la preparacion de esta y el uso del compuesto para preparar un medicamento | |
| AR060838A1 (es) | Formulaciones de dosificacion solida | |
| BR0215175A (pt) | Métodos para a granulação úmida de azitromicina | |
| EA201001031A1 (ru) | Замещенные эфиры 4-{3-[6-амино-9-(3,4-дигидрокситетрагидрофуран-2-ил)-9h-пурин-2-ил]проп-2-инил}пиперидин-1-карбоновых кислот и их применение | |
| TNSN07337A1 (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
| GT200500358A (es) | Compuestos organicos | |
| PL2094308T3 (pl) | Trwały preparat pozajelitowy zawierający inhibitor RSV o strukturze benzodiazepiny | |
| CR9407A (es) | Tetrahidropiridoazepin-8-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
| DK2197428T3 (da) | Forbedret farmaceutisk sammensætning, der indeholder et pyrrolidon-antikrampemiddel, og fremgangsmåde til fremstilling heraf | |
| CL2008001325A1 (es) | Compuestos derivados de pirazol-piridinona; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar inflamacion, enfermedad de paget, osteoartritis, alzheimer, entre otras enfermedades. | |
| CO5611102A2 (es) | Sales estables del acido o-acetilsalicilico con aminoacidos basicos ii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |